The microbial community inhabiting skin is an important part of its defense, acting to control immune responses and to influence susceptibility to pathogens. In this issue, Volz et al. report that Vitreoscilla filiformis extracts modulate mouse cutaneous inflammatory responses induces of interleukin-10 production in dendritic cells and priming of regulatory T cells. These findings in a mouse model of atopic dermatitis advance observations of links between bacteria and host immunity, and they provide further evidence for novel therapeutic strategies to treat inflammation in skin.
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Journal of Investigative Dermatology (2014 Dermatology ( ) 134, 11-14. doi:10.1038 Dermatology ( /jid.2013 Microbial mutualism Mammalian skin is colonized by with diverse microbial communities (Grice et al., 2009; Nakatsuji et al., 2013) . Knowledge of these associations is based on observations that skin provides environmental niches in which such organisms survive, whereas at the same time symbiotically providing functioning to maintain skin health. Several recent studies have provided details regarding the mechanisms by which bacterial products from commensal bacteria modulate host immunity, thus advancing, at least in part, the ''pseudo-science'' label formerly assigned to claims of benefits from undefined biological potions. Although at one time the scientific community considered bacterial products only to stimulate inflammation, we now know that some products can suppress inflammation as well. For example, we demonstrated that lipoteichoic acid produced by the human skin commensal bacterium Staphylococcus epidermidis (S. epidermidis) suppresses skin inflammation from injury through a Toll-like receptor 2 (TLR2)-dependent mechanism (Lai et al., 2009 ). More recently, skin commensal bacteria have been shown to provide benefit by enhancing cutaneous T-cell functions via activation of interleukin (IL)-1 signaling (Naik et al., 2012) . Indeed, mono-colonization of germ-free mouse skin by S. epidermidis protected these mice against pathogen infection in comparison to germ-free skin (Naik et al., 2012) . Commensal skin microbes such as S. epidermidis also provide benefit by producing natural antimicrobial substances that aid in resisting pathogens (Cogen et al., 2010) . In total, the actions of commensal skin bacteria support the hypothesis that a mutually beneficial relationship exists between microbes and human skin (Gallo and Nakatsuji, 2011; Table 1 ). In this issue, Volz et al. (2013) report that products of a non-pathogenic bacterium, V. filiformis, has the capacity to suppress atopic dermatitis (AD)-like inflammation in mice. These findings also support the concept that we are on the verge of a new age of skin therapies, exploiting knowledge of the function of microbial communities and redefining what should considered ''self'' and ''non-self.''
Dysbiosis and AD
The concept of a mutualistic beneficial relationship between surface bacteria and skin is supported further by observations concerning disruption of this interaction. For example, AD is a classic inflammatory skin disorder that has long been known to be associated with dysbiosis (a state of microbial imbalance) of the surface microbial community (Leyden et al., 1974) . These early observations have been repeated and extended with modern 16S sequencing approaches (Kong et al., 2012) . So far, however, clear evidence for a cause and effect relationship between AD and microbial dysbiosis has remained elusive. Thus, the relationship between disease and dysbiosis remains an attractive hypothesis awaiting experimental proof.
AD is a complex, multifactorial disorder with several genetic risk factors but major environmental triggers. Patients exhibit alterations in T-cell homeostasis, suppression of cathelicidin and b-defensin antimicrobial responses, and physical barrier defects (Ong et al., 2002; Kupper and Fuhlbrigge, 2004; Palmer et al., 2006) . The combination of physical barrier and antimicrobial barrier defects likely drives the microbial dysbiosis, which disrupts further the balance of cellular immunity necessary to establish inflammatory equilibrium with the external environment. Regulatory T (Treg) cells are crucial mediators of the balance between tolerance to antigens (both ''self'' and foreign) and immune responses. The secretion of anti-inflammatory cytokines, such as IL-10, is one mechanism by which this balance is achieved (Sakaguchi et al., 2010) . Although it remains controversial whether defects in Treg cells contribute to the pathogenesis of AD, depletion of FoxP3 þ Treg cells in mice drives AD-like symptoms such as expression of Th2 cytokines and elevated serum IgE (Fyhrquist et al., 2012) . Because of the recognized associations between products of bacteria and Treg cell function, AD provides an ideal model system to appreciate the potential benefits of a ''normal'' microbiome. More recently, it has been demonstrated that short-chain free fatty acids, fermentation metabolites of dietary fiber by intestinal commensal microbiota, increase the frequency and number of Foxp3 þ Treg cells in the large intestine through binding to G-protein coupled receptor 43 (Smith et al., 2013) . Because free fatty acids are also predominant components in human sebum, such a Treg response may be involved in maintaining inflammatory homeostasis in skin. Overall, current data suggest that hosts and microbes communicate in many different ways to arrive at a similar end point, inflammatory homeostasis. However, the immune mechanisms in skin that manipulate inflammation in general, or Treg cell function in particular, remain poorly understood.
Exploiting the therapeutic potential of bacteria
The beneficial activities of commensal bacteria in immune homeostasis have led to several therapeutic strategies that seek to target inflammatory and autoimmune diseases, especially for inflammatory bowel disease. For example, it has been demonstrated recently that transplantation of reconstruction of a healthy intestinal microbial ecosystem from purified bacterial cultures obtained from stool of healthy donors (RePOOPulate) is capable of curing colitis induced by antibiotic-resistant Clostridium difficile infection (Petrof et al., 2013) . In addition, transplantation of a 
Clinical Implications
Epicutaneous application of a lysate of a bacterium found in thermal spas (Vitreoscilla filiformis) suppresses inflammation in mice.
V. filiformis lysates induce Toll-like receptor 2-dependent production of interleukin-10 (IL-10) from dendritic cells and prime regulatory T cells.
Targeted production of IL-10 by non-pathogenic bacteria is a promising approach to topical anti-inflammatory therapy.
mixture of commensal Clostridium species isolated from a healthy human fecal samples successfully induced the accumulation and functional maturation of Treg cells in the colon, resulting in attenuation of disease in mouse models of colitis and allergic diarrhea (Atarashi et al., 2013). Oral probiotic treatment, which presumably would effect the gut microbiome, increased the frequency of FoxP3 þ Treg cells in skin draining lymph nodes in a murine model of cutaneous allergy, and it decreased inflammation, as well (Hacini-Rachinel et al., 2009). Thus, the intestinal microbiome may also influence the skin. In a human study, oral treatment with a combination of probiotics strains (Lactobacillus salivarius and Bifidobacterium breve) for 3 months significantly improved ratio of Th17/Treg cells in peripheral blood of adult AD patient as well as decreasing the severity of skin inflammation (Iemoli et al., 2012) . These observations suggest a link between the intestinal microenvironment and skin health, a topic of controversy in the management of AD (Boyle et al., 2009). Part of this controversy may stem from different activities of the probiotic strains that were employed and a lack of molecular mechanistic detail concerning the observations.
Treg cells hit the spa
Volz et al., now shows that epicutaneous administration of a lysate of V. filiformis beneficially modulates the local skin immunity, adding important mechanistic insight into these processes. Notably, the signal of V. filiformis was transmitted successfully to cells below the skin surface, an observation at odds with classic concepts about the tight barrier properties of epidermis, but consistent with our recent observations that influences from the microbiome penetrate into the dermis and exist in equilibrium across an epidermal barrier (Nakatsuji et al., 2013) .
V. filiformis is a gram-negative bacterium originally found in thermal spa water. Because V. filiformis is thought to contribute to the beneficial effect of spa water, a bacterial lysate of V. filiformis has been used informally as dermatological treatment (Gueniche  et al., 2008) . Indeed, clinical studies have demonstrated that a topical formulation of V. filiformis lysate significantly improved AD and seborrheic dermatitis in comparison to placebo treatment (Gueniche et al., 2006; Gueniche et al., 2008) . In this issue, Volz et al.
(2013) take these observations a step further by suggesting that the antiinflammatory effect of V. filiformis is by activating cutaneous Treg cells. They show a lysate of V. filiformis induces maturation of IL-10 þ DCs. V. filiformisinduced DC maturation was independent of MyD88, an essential mediator for signal transduction by TLR2 and IL-1R, whereas production of IL-10 was decreased greatly in the absence of MyD88 or TLR2. Thus, V. filiformis can trigger maturation of DC by multiple pathways, but requires TLR2 for IL-10 production. It remains unclear whether TLR1 or TLR6, which act in complex with TLR2, is required for this pathway. The acquisition of invasive properties in melanoma is associated with a high proclivity for metastasis, but the underlying pathways are poorly characterized. The Hippo pathway has an important role in organ size control and is dysregulated in some type of tumors. The present study, ''Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma'' by NalletStaub et al., 2013, provides the first in-depth analysis of expression of the Hippo pathway effectors YAP (yes-associated protein) and TAZ (Tafazzin) in human melanocytic lesions. Importantly, results from this study demonstrate a causal relationship between YAP/TAZ levels and melanoma cell tumorigenicity and invasiveness. (2014) 134, 14-16. doi:10.1038/jid.2013.372 The Salvador/Warts/Hippo signaling pathway, here simply referred to as the Hippo pathway, is an evolutionarily conserved regulator of organ size and tumorigenesis (Harvey et al., 2013 Nallet-Staub et al. (2013) analyzed YAP and TAZ expression in melanoma cell lines and melanocytic lesions. While TAZ expression was elevated in melanoma cell lines compared with normal human melanocytes, these levels were variable, and no differences in YAP1/2 expression were noted. Furthermore, immunohistochemical analyses showed no differences in YAP and TAZ staining between benign nevi and superficial spreading melanoma. Thus, YAP and TAZ do not represent biomarker candidates for melanoma invasion. However, the data does support a causal relationship between Hippo signaling and melanoma invasive properties. YAP and TAZ knockdown in melanoma lines with high basal YAP/TAZ levels inhibited in vitro tumorigenicity, Matrigel
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